Nihon Kohden Corp
TSE:6849

Watchlist Manager
Nihon Kohden Corp Logo
Nihon Kohden Corp
TSE:6849
Watchlist
Price: 2 151.5 JPY -1.06% Market Closed
Market Cap: 367.8B JPY
Have any thoughts about
Nihon Kohden Corp?
Write Note

Nihon Kohden Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nihon Kohden Corp
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Nihon Kohden Corp
TSE:6849
Operating Income
ÂĄ17.2B
CAGR 3-Years
-21%
CAGR 5-Years
-1%
CAGR 10-Years
0%
Terumo Corp
TSE:4543
Operating Income
ÂĄ161.3B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
9%
Olympus Corp
TSE:7733
Operating Income
ÂĄ109.4B
CAGR 3-Years
-4%
CAGR 5-Years
6%
CAGR 10-Years
3%
Sysmex Corp
TSE:6869
Operating Income
ÂĄ89.1B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
9%
JEOL Ltd
TSE:6951
Operating Income
ÂĄ35.1B
CAGR 3-Years
76%
CAGR 5-Years
37%
CAGR 10-Years
23%
Fukuda Denshi Co Ltd
TSE:6960
Operating Income
ÂĄ23.2B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
8%
No Stocks Found

Nihon Kohden Corp
Glance View

Market Cap
358.5B JPY
Industry
Health Care

Nihon Kohden Corp., founded in 1951, has evolved into a pioneering force in the medical technology landscape, blending innovation with a storied heritage. This Tokyo-based firm established its foothold by developing advanced medical electronic devices, initially focusing on EEG (electroencephalography) machines. As medical science rapidly advanced, Nihon Kohden expanded its portfolio to include a range of diagnostic and monitoring equipment. Today, the company's product line encompasses patient monitors, defibrillators, electrocardiographs, and clinical information systems, serving various healthcare domains. This focus on critical care and diagnostics creates consistent demand across global hospitals and clinics, reinforcing its reputation as a dependable partner in medical excellence. Financially, Nihon Kohden's business model thrives on a dual revenue structure: product sales and after-sales service. By manufacturing and distributing complex equipment directly and through a network of distributors, the company captures a significant share of initial capital expenditure in healthcare institutions. Furthermore, it enhances this income by offering ongoing equipment maintenance, training, and customer support, forming long-term relationships with healthcare providers. These services ensure not only a steady revenue stream beyond the initial sale but also brand loyalty and trust in an industry where precision and reliability are paramount. As it continues to innovate, Nihon Kohden's commitment to addressing the evolving needs of healthcare practitioners fortifies its market position and operational success.

Intrinsic Value
1 550.78 JPY
Overvaluation 28%
Intrinsic Value
Price

See Also

What is Nihon Kohden Corp's Operating Income?
Operating Income
17.2B JPY

Based on the financial report for Sep 30, 2024, Nihon Kohden Corp's Operating Income amounts to 17.2B JPY.

What is Nihon Kohden Corp's Operating Income growth rate?
Operating Income CAGR 10Y
0%

Over the last year, the Operating Income growth was -20%. The average annual Operating Income growth rates for Nihon Kohden Corp have been -21% over the past three years , -1% over the past five years .

Back to Top